These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2410475)

  • 1. Pulmonary synthesis, release, and metabolism of prostaglandins.
    Robinson C; Hardy CC; Holgate ST
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):265-71. PubMed ID: 2410475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
    Holgate ST; Burns GB; Robinson C; Church MK
    J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma.
    Schulman ES; Newball HH; Demers LM; Fitzpatrick FA; Adkinson NF
    Am Rev Respir Dis; 1981 Oct; 124(4):402-6. PubMed ID: 6170242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma.
    Beasley R; Varley J; Robinson C; Holgate ST
    Am Rev Respir Dis; 1987 Nov; 136(5):1140-4. PubMed ID: 2960256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The generation of prostaglandins by human lung and their effects on airway function in man.
    Robinson C; Holgate ST
    Bull Eur Physiopathol Respir; 1986; 22 Suppl 7():81-90. PubMed ID: 3513876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin and histamine release from stimulated rat peritoneal mast cells.
    Ennis M; Barrow SE; Blair IA
    Agents Actions; 1984 Apr; 14(3-4):397-400. PubMed ID: 6203356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.
    Hardy CC; Holgate ST; Robinson C
    Br J Pharmacol; 1986 Mar; 87(3):563-8. PubMed ID: 3467804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids.
    Schleimer RP; Davidson DA; Lichtenstein LM; Adkinson NF
    J Immunol; 1986 Apr; 136(8):3006-11. PubMed ID: 3082976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunoglobulin E- and calcium-dependent release of histamine and eicosanoids from human dispersed mastocytosis spleen cells.
    Robinson C; Benyon RC; Agius RM; Jones DB; Wright DH; Holgate ST
    J Invest Dermatol; 1988 Mar; 90(3):359-65. PubMed ID: 2450144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
    Lewis RA; Soter NA; Diamond PT; Austen KF; Oates JA; Roberts LJ
    J Immunol; 1982 Oct; 129(4):1627-31. PubMed ID: 6809826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells.
    Robinson C; Benyon C; Holgate ST; Church MK
    J Invest Dermatol; 1989 Sep; 93(3):397-404. PubMed ID: 2504819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways.
    Beasley CR; Robinson C; Featherstone RL; Varley JG; Hardy CC; Church MK; Holgate ST
    J Clin Invest; 1987 Mar; 79(3):978-83. PubMed ID: 3469218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
    Schleimer RP; Schulman ES; MacGlashan DW; Peters SP; Hayes EC; Adams GK; Lichtenstein LM; Adkinson NF
    J Clin Invest; 1983 Jun; 71(6):1830-5. PubMed ID: 6134755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
    Wells E; Harper ST; Jackson CG; Mann J; Eady RP
    J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure.
    Woodward DF; Williams LS; Chen J
    Ophthalmic Res; 1989; 21(6):428-35. PubMed ID: 2626239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator release from human lung under conditions of reduced oxygen tension.
    Peters SP; Lichtenstein LM; Adkinson NF
    J Pharmacol Exp Ther; 1986 Jul; 238(1):8-13. PubMed ID: 2425080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative transformations of arachidonic acid in human dispersed lung cells: disparity between the utilization of endogenous and exogenous substrate.
    Harvey J; Holgate ST; Peters BJ; Robinson C; Walker JR
    Br J Pharmacol; 1985 Oct; 86(2):417-26. PubMed ID: 3931732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ; Peachell PT; Lichtenstein LM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of inflammatory mediator release from purified human lung mast cells.
    Schleimer RP; MacGlashan DW; Peters SP; Pinckard RN; Adkinson NF; Lichtenstein LM
    Am Rev Respir Dis; 1986 Apr; 133(4):614-7. PubMed ID: 3485946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.